BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3124458)

  • 1. Primary polycythaemia, essential thrombocythaemia and myelofibrosis--three facets of a single disease process?
    Adams JA; Barrett AJ; Beard J; McCarthy DM
    Acta Haematol; 1988; 79(1):33-7. PubMed ID: 3124458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating erythroid and megakaryocytic progenitors in polycythaemia vera and essential thrombocythaemia.
    Florensa L; Besses C; Almarcha J; Lafuente R; Palou L; Pedro C; Sans-Sabrafen J; Woessner S
    Eur J Haematol; 1989 Nov; 43(5):417-22. PubMed ID: 2693129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders.
    Hibbin JA; Njoku OS; Matutes E; Lewis SM; Goldman JM
    Br J Haematol; 1984 Jul; 57(3):495-503. PubMed ID: 6743569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous erythroid colony formation in myeloproliferative diseases does not depend on T cells.
    Robak T; Hast R; Goldman JM
    Exp Hematol; 1986 Mar; 14(3):197-201. PubMed ID: 3485053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders.
    Douer D; Fabian I; Cline MJ
    Br J Haematol; 1983 Jul; 54(3):373-81. PubMed ID: 6574788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia.
    Andréasson B; Swolin B; Kutti J
    Eur J Haematol; 2002 Apr; 68(4):189-93. PubMed ID: 12071933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis.
    Han ZC; Briere J; Nedellec G; Abgrall JF; Sensebe L; Parent D; Guern G
    Eur J Haematol; 1988 Feb; 40(2):130-5. PubMed ID: 3345826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating granulocytic and erythroid progenitor cells in chronic granulocytic leukaemia.
    Goldman JM; Shiota F; Th'ng KH; Orchard KH
    Br J Haematol; 1980 Sep; 46(1):7-13. PubMed ID: 6932958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating haematopoietic progenitors in myelofibrosis.
    Partanen S; Ruutu T; Vuopio P
    Scand J Haematol; 1982 Oct; 29(4):325-30. PubMed ID: 7178838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor beta 1, produced in normal amount, in patients with essential thrombocythaemia.
    Zauli G; Visani G; Catani L; Vianelli N; Gugliotta L; Capitani S
    Br J Haematol; 1993 Jan; 83(1):14-20. PubMed ID: 8435322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic characteristics of circulating granulocyte-macrophage progenitors (CFU-GM) in idiopathic myelofibrosis and polycythaemia vera defined by monoclonal antibodies.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):17-28. PubMed ID: 2619501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences among myeloproliferative disorders in the behavior of their restricted progenitor cells in culture.
    Croizat H; Amato D; McLeod DL; Eskinazi D; Axelrad AA
    Blood; 1983 Sep; 62(3):578-84. PubMed ID: 6603877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic characteristics of erythropoietin dependent and independent erythroid progenitors (BFU-E and CFU-E) in polycythaemia vera and idiopathic myelofibrosis defined by monoclonal antibodies.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1988; 36(6):733-47. PubMed ID: 3254121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia.
    Florensa L; Besses C; Woessner S; Solé F; Acín P; Pedro C; Sans-Sabrafen J
    Leukemia; 1995 Feb; 9(2):271-3. PubMed ID: 7869763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early loss of circulating hemopoietic progenitors in HIV-1-infected subjects.
    Bagnara GP; Zauli G; Giovannini M; Re MC; Furlini G; La Placa M
    Exp Hematol; 1990 Jun; 18(5):426-30. PubMed ID: 1970962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The morphology features of bone marrow in the prefibrotic-early primary myelofibrosis].
    Gong XB; Zhang XH; Lu XG; Tang QS; Gao X; Yang J
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):25-30. PubMed ID: 22575188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megakaryocytopoiesis in polycythemia vera: characterization by megakaryocytic progenitors (CFU-Meg) in vitro and quantitation of marrow megakaryocytes.
    Kimura H; Ohkoshi T; Matsuda S; Uchida T; Kariyone S
    Acta Haematol; 1988; 79(1):1-6. PubMed ID: 3124455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating erythroid progenitors in patients with 'spent' polycythaemia vera and myelofibrosis with myeloid metaplasia.
    Kornberg A; Fibach E; Treves A; Goldfarb A; Rachmilewitz EA
    Br J Haematol; 1982 Dec; 52(4):573-8. PubMed ID: 7138787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megakaryocyte colony formation in chronic myeloid leukemia and myelofibrosis.
    Juvonen E
    Leuk Res; 1988; 12(9):751-6. PubMed ID: 3193813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.